Artelo Biosciences

(NASDAQ) ARTL

Current Price$1.85

Market Cap$1.73M

Since IPO (2017)-100%

5 Year-99%

1 Year-89%

1 Month-65%

Artelo Biosciences Financials at a Glance

Market Cap

$1.73M

Revenue (TTM)

$0.00

Net Income (TTM)

$13.46M

EPS (TTM)

$-38.92

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$1.85

Volume

8,612,774.414

Open

$2.24

Price

$1.85

Volume

8,612,774.414

Open

$2.24

Previous Close

$1.84

Daily Range

$1.77 - $2.34

52-Week Range

$1.77 - $85.80

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$1.85

Volume

8,612,774.414

Open

$2.24

Previous Close

$1.84

Daily Range

$1.77 - $2.34

52-Week Range

$1.77 - $85.80

ARTL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Artelo Biosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Gregory D. Gorgas, MBA

Website

www.artelobio.com

Headquarters

Solana Beach, CA 92075, US

ARTL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-368%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.73M

Shares Outstanding

938.10K

Volume

8.61M

Avg. Volume

3.51M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.40M

EBITDA

$12.54M

Operating Cash Flow

$8.52M

Capital Expenditure

$0.00

Free Cash Flow

$8.52M

Cash & ST Invst.

$600.00K

Total Debt

$693.00K

Artelo Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.73M

N/A

Market Cap/Employee

$287.70K

N/A

Employees

N/A

Net Income

$2.96M

-24.7%

EBITDA

$2.83M

-19.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$9.52M

+1362.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$18.00K

-69.5%

Short Term Debt

$737.00K

+1947.2%

Return on Assets

-1.08%

N/A

Return on Invested Capital

-1.75%

N/A

Free Cash Flow

$1.19M

+25.4%

Operating Cash Flow

$1.19M

+25.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.65+51.10%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.02-13.09%

SPRCSciSparc Ltd.

SPRCSciSparc Ltd.$4.82-3.19%

LIPOLipella Pharmaceuticals Inc.

LIPOLipella Pharmaceuticals Inc.$0.04-10.00%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$0.29-42.06%

PBMPsyence Biomedical Ltd.

PBMPsyence Biomedical Ltd.$4.91-2.58%

CARMCarisma Therapeutics, Inc.

CARMCarisma Therapeutics, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$108.77-0.06%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

Questions About ARTL

What is the current price of Artelo Biosciences?

Artelo Biosciences is trading at $1.84 per share.

What is the 52-week range for Artelo Biosciences?

Over the past 52 weeks, Artelo Biosciences has traded between $1.77 and $85.80.

How much debt does Artelo Biosciences have?

As of the most recent reporting period, Artelo Biosciences reported total debt of $719,000.

How much cash does Artelo Biosciences have on hand?

Artelo Biosciences reported $10.27M in cash and cash equivalents in its most recent financial results.

What is Artelo Biosciences’s dividend yield?

Artelo Biosciences does not currently have a dividend yield.

Artelo Biosciences

Artelo Biosciences Financials at a Glance

ARTL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Artelo Biosciences

ARTL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Artelo Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARTL

What is the current price of Artelo Biosciences?

What is the 52-week range for Artelo Biosciences?

How much debt does Artelo Biosciences have?

How much cash does Artelo Biosciences have on hand?

What is Artelo Biosciences’s dividend yield?

Premium Investing Services